Chemists threaten to join lockdown, seek Covid-19 vaccination on priority

The medical devices makers' industry body, too, has written to the NITI Aayog seeking vaccination on priority.

Pharmacy, medical shop
An organisation representing around 940,000 chemists on Thursday said, “Vaccinate chemists with priority, else all 9.4 lakh chemists are ready to join corona lockdown.”
Sohini Das Mumbai
2 min read Last Updated : May 21 2021 | 12:38 AM IST
Chemists have threatened to join the lockdown after their requests to be treated as essential services workers for vaccination was not accepted by the government. The medical devices makers’ industry body, too, has written to the NITI Aayog seeking vaccination on priority.

An organisation representing around 940,000 chemists on Thursday said, “Vaccinate chemists with priority, else all 9.4 lakh chemists are ready to join corona lockdown.” Jagannath Shinde, president of the chemists lobby All India Organisation of Chemists and Druggists (AIOCD), said despite dangers every chemist has been working to maintain the availability of essential medicines.


The AIOCD said its members may join the lockdown, as they were “sidelined while considering vaccination priority”. Rajiv Singhal, AIOCD general secretary, told Business Standard that about 5 million people would have to be vaccinated. “Around 675 of our members have died due to Covid-19,” Singhal added.

The Association of Indian Medical Devices Industry (AiMED) too wrote a letter to VK Paul, member health of NITI Aayog, on Wednesday requesting priority allocation of vaccines to employees of medical devices companies. It has mentioned that its earlier requests did not receive any response.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Chemists strikepharmacyCoronavirus VaccineVaccinationMedical device industryNiti AayogHealth Ministry

Next Story